Some smaller p53 isoforms inhibit the wild-type p53 [339], so the unbalancing expressions of different p53 splice variants are involved in tumorigenesis [332] and, moreover, are related to the clinical features of BC and its outcomes [339,340]. This evidence concerns the gene TP53 and breast cancer.